Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIKMA

  • FDA Approval
  • Nov. 21, 2024, 09:48 UTC
  • 55
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

CHARTWELL MOLECULES

  • FDA Approval
  • Nov. 21, 2024, 09:48 UTC
  • 60
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

CHARTWELL

  • FDA Approval
  • Nov. 21, 2024, 09:48 UTC
  • 58
  • 0 comments

FDA approve HYDROMORPHONE HYDROCHLORIDE

Comment Full text

CHARTWELL RX

  • FDA Approval
  • Nov. 21, 2024, 09:48 UTC
  • 56
  • 0 comments

FDA approve MELOXICAM

Comment Full text

CHARTWELL

  • FDA Approval
  • Nov. 21, 2024, 09:48 UTC
  • 53
  • 0 comments

FDA approve HYDROMORPHONE HYDROCHLORIDE

Comment Full text

IMPAX

  • FDA Approval
  • Nov. 20, 2024, 19:35 UTC
  • 61
  • 0 comments

FDA approve EPINEPHRINE

Comment Full text

SUN PHARM

  • FDA Approval
  • Nov. 20, 2024, 09:51 UTC
  • 50
  • 0 comments

FDA approve IPRATROPIUM BROMIDE

Comment Full text

SLATE RUN PHARMA

  • FDA Approval
  • Nov. 20, 2024, 09:51 UTC
  • 59
  • 0 comments

FDA approve EPTIFIBATIDE

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • Nov. 20, 2024, 09:51 UTC
  • 50
  • 0 comments

FDA approve DIGOXIN

Comment Full text

STIRA

  • FDA Approval
  • Nov. 20, 2024, 09:51 UTC
  • 53
  • 0 comments

FDA approve CHROMIC CHLORIDE

Comment Full text
  • Previous
  • 310
  • 311
  • 312
  • 313
  • 314
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158458)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin